For a patient with gestational diabetes at 36 weeks undergoing weekly surveillance, where should she be monitored?

For a patient with gestational diabetes at 36 weeks undergoing weekly surveillance, where should she be monitored?

• A. Monitor in the Outpatient Antepartum Testing/Observation Unit
• B. Inpatient Labor and Delivery unit
• C. Neonatal Intensive Care Unit
• D. Home monitoring

Answer: (A)

Monitoring in the Outpatient Antepartum Testing/Observation Unit is the best choice for weekly surveillance at 36 weeks with gestational diabetes. This setting is designed for high-risk pregnancies that require regular fetal testing and maternal assessment without admitting the patient to labor and delivery. It allows scheduled checks such as nonstress tests, targeted ultrasound if needed, and close attention to maternal glucose and vitals, with the ability to escalate care quickly if any concerning findings arise. Inpatient labor and delivery is reserved for active labor or imminent delivery, not routine surveillance. The neonatal intensive care unit cares for the newborn after birth, not for antenatal monitoring. Home monitoring lacks access to formal tests and immediate clinical support, making it unsuitable for ongoing weekly surveillance in late pregnancy.

Monitoring in the Outpatient Antepartum Testing/Observation Unit is the best choice for weekly surveillance at 36 weeks with gestational diabetes. This setting is designed for high-risk pregnancies that require regular fetal testing and maternal assessment without admitting the patient to labor and delivery. It allows scheduled checks such as nonstress tests, targeted ultrasound if needed, and close attention to maternal glucose and vitals, with the ability to escalate care quickly if any concerning findings arise.

Inpatient labor and delivery is reserved for active labor or imminent delivery, not routine surveillance. The neonatal intensive care unit cares for the newborn after birth, not for antenatal monitoring. Home monitoring lacks access to formal tests and immediate clinical support, making it unsuitable for ongoing weekly surveillance in late pregnancy.